Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neovascular Endothelium (N/A)
- Target
- N/A
- Molecular classification
- Cellular component, Endothelial cells, Vascular endothelium
01
Overview
Neovascular endothelium refers to the endothelial cells lining newly formed blood vessels. These cells exhibit distinct molecular and functional characteristics compared to mature endothelium, playing a critical role in angiogenesis, vascular permeability, and immune cell trafficking. The neovascular endothelium is a key target in diseases characterized by abnormal angiogenesis, such as cancer, ocular diseases, and chronic inflammation, where targeted therapies aim to inhibit vessel formation and disrupt disease progression.
- Other names
- Newly formed blood vessel endotheliumTumor vasculatureActivated endotheliumAngiogenic endothelium
02
Mechanism of action
Varies depending on the specific drug and target; examples include inhibition of VEGFR2 signaling, disruption of integrin-mediated cell adhesion, and targeted delivery of cytotoxic agents to neovascular endothelium.
03
Biological functions
AngiogenesisRegulation of vascular permeabilityHemostasisImmune cell traffickingVascular tone regulationNutrient and oxygen supply to tissuesVessel remodeling
04
Disease associations
Cancer progressionDiabetic retinopathyAge-related macular degenerationChronic inflammationAtherosclerosisThrombosis
05
Safety considerations
Systemic toxicity of anti-angiogenic agentsDevelopment of resistance to anti-angiogenic therapiesImpaired wound healingIncreased risk of thrombosisHypertension
06
Interacting drugs
VEGFR2 inhibitors
3 more in the full profile.
07
Biomarkers
VEGFR2 expression levelsIntegrin αvβ3 expression levelsE-selectin expression levelsCD13 expression levelsCirculating endothelial cells (CECs)
Beyond the preview
Go deeper on Neovascular Endothelium (N/A).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Neovascular Endothelium (N/A).